Results 241 to 250 of about 13,150,510 (391)

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

NO_x-Free Leaching Methods for Efficient Silver and Aluminium Recovery from Crystalline Silicon Solar Cells. [PDF]

Materials (Basel)
Zubas AR, Griškonis E, Denafas G, Makarevičius V, Kriūkienė R, Kruopienė J.   +5 more
europepmc   +1 more source

CHEMICAL TECHNOLOGY DIVISION ANNUAL PROGRESS REPORT FOR PERIOD ENDING MAY 31, 1963

, 1963

openalex   +2 more sources

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Plastic-Associated Chemicals: Late Lessons from Early Equilibrium Partitioning Science. [PDF]

Environ Sci Technol
Leslie HA, Jahnke A, Rojo-Nieto E, Arp HPH.   +3 more
europepmc   +1 more source

For chemical technology that respects the environment, call us. [PDF]

, 1981

openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

UNH Nonlethal Technology Symposium in Portsmouth Will Discuss Biological and Chemical Weapons [PDF]

, 2000
Billings, Kim
core   +5 more sources

Optimization of Diamond Polishing Process for Sub-Nanometer Roughness Using Ar/O₂/SF₆ Plasma. [PDF]

Materials (Basel)
Zhao L, Wang X, Jiang M, Zhao C, Jiang N, Nishimura K, Yi J, Fang S.   +7 more
europepmc   +1 more source

CHEMICAL PROCESSING TECHNOLOGY QUARTERLY PROGRESS REPORT, JULY-SEPTEMBER, 1960

, 1961
J.R. ed. Bower
openalex   +2 more sources